Login / Signup

Which men benefit from prostate cancer screening? Prostate cancer mortality by subgroup in the European Randomised Study of Screening for Prostate Cancer.

Niko PasanenKirsi TalalaSebastiaan RemmersTeuvo L J TammelaJonas HugossonMonique J RoobolKimmo TaariRebecka Arnsrud GodtmanChris BangmaAnssi Auvinen
Published in: BJU international (2024)
We were unable to unequivocally identify the optimal age group for screening, as mortality reduction differed among centres and age groups. Instead, the screening effect appears to depend on screening duration, and the number and frequency of screening rounds. PCa mortality reduction by screening is largely attributable to stage shift.
Keyphrases
  • prostate cancer
  • radical prostatectomy
  • clinical trial
  • cardiovascular events
  • randomized controlled trial
  • study protocol
  • middle aged